(S)-nicotine increases expression ISO VCAN (Homo sapiens) 6480464 Nicotine results in increased expression of VCAN mRNA CTD PMID:23825647 1-naphthyl isothiocyanate increases expression ISO Vcan (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of VCAN mRNA CTD PMID:30723492 1-nitropyrene increases expression ISO VCAN (Homo sapiens) 6480464 1-nitropyrene results in increased expression of VCAN mRNA CTD PMID:19041380 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of VCAN mRNA CTD PMID:19484750 and PMID:30077407 17beta-estradiol multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VCAN mRNA CTD PMID:32741896 17beta-estradiol multiple interactions EXP 6480464 [Polyphenols co-treated with Estradiol] results in increased expression of VCAN mRNA CTD PMID:30077407 17beta-estradiol multiple interactions ISO VCAN (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of VCAN mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of VCAN mRNA CTD PMID:20660070 and PMID:30165855 17beta-estradiol 3-benzoate multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VCAN mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO VCAN (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO VCAN (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of VCAN mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO VCAN (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of VCAN mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Vcan (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of VCAN mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Vcan (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VCAN mRNA CTD PMID:32109520 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VCAN mRNA CTD PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VCAN mRNA CTD PMID:18691609 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Vcan (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of VCAN mRNA CTD PMID:22808131 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO VCAN (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VCAN mRNA CTD PMID:20106945 and PMID:21632981 2,4,6-tribromophenol increases expression ISO VCAN (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA CTD PMID:18200517 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO Vcan (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of VCAN mRNA] and IL1B affects the reaction [Glucosamine results in decreased expression of VCAN mRNA] CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Vcan (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of VCAN mRNA CTD PMID:17109745 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression ISO VCAN (Homo sapiens) 6480464 Puromycin Aminonucleoside results in decreased expression of VCAN mRNA and Puromycin Aminonucleoside results in decreased expression of VCAN protein CTD PMID:15585670 3,3',4,4',5-pentachlorobiphenyl increases expression ISO VCAN (Homo sapiens) 6480464 3 more ... CTD PMID:35618242 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of VCAN mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO VCAN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of VCAN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VCAN mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Vcan (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of VCAN mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of VCAN mRNA CTD PMID:30951980 and PMID:37611474 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of VCAN mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO VCAN (Homo sapiens) 6480464 Decitabine affects the expression of VCAN mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression ISO Vcan (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of VCAN mRNA CTD PMID:24780913 acrylamide decreases expression ISO Vcan (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of VCAN mRNA CTD PMID:28959563 acrylamide decreases expression ISO VCAN (Homo sapiens) 6480464 Acrylamide results in decreased expression of VCAN mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO VCAN (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of VCAN protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO VCAN (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of VCAN intron CTD PMID:30157460 aflatoxin B1 increases expression ISO VCAN (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of VCAN mRNA CTD PMID:22100608 and PMID:32234424 aflatoxin M1 decreases expression ISO VCAN (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of VCAN mRNA CTD PMID:30928695 aldehydo-D-glucosamine multiple interactions ISO Vcan (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of VCAN mRNA] and IL1B affects the reaction [Glucosamine results in decreased expression of VCAN mRNA] CTD PMID:17109745 aldehydo-D-glucosamine decreases expression ISO Vcan (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of VCAN mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression ISO VCAN (Homo sapiens) 6480464 Tretinoin results in increased expression of VCAN mRNA CTD PMID:23724009 amiodarone affects expression ISO VCAN (Homo sapiens) 6480464 Amiodarone affects the expression of VCAN protein alternative form CTD PMID:26515726 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of VCAN protein alternative form CTD PMID:26515726 amiodarone multiple interactions EXP 6480464 Amiodarone affects the reaction [VCAN protein alternative form affects the expression of SNAI1 protein] and Amiodarone affects the reaction [VCAN protein alternative form affects the phosphorylation of EGFR protein] CTD PMID:26515726 amphetamine increases expression ISO Vcan (Rattus norvegicus) 6480464 Amphetamine results in increased expression of VCAN mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO VCAN (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of VCAN mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO VCAN (Homo sapiens) 6480464 arsenite results in decreased expression of VCAN mRNA CTD PMID:23974009 astemizole decreases expression ISO Vcan (Rattus norvegicus) 6480464 Astemizole results in decreased expression of VCAN mRNA CTD PMID:20221588 atrazine affects methylation ISO Vcan (Rattus norvegicus) 6480464 Atrazine affects the methylation of VCAN gene CTD PMID:35440735 benzene increases expression ISO VCAN (Homo sapiens) 6480464 Benzene results in increased expression of VCAN mRNA CTD PMID:19162166 benzo[a]pyrene increases mutagenesis ISO VCAN (Homo sapiens) 6480464 Benzo(a)pyrene results in increased mutagenesis of VCAN gene CTD PMID:25435355 benzo[a]pyrene increases expression ISO VCAN (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of VCAN mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO VCAN (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of VCAN 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO VCAN (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of VCAN mRNA CTD PMID:21632981 benzo[a]pyrene affects expression ISO VCAN (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of VCAN mRNA CTD PMID:20106945 beta-D-glucosamine multiple interactions ISO Vcan (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of VCAN mRNA] and IL1B affects the reaction [Glucosamine results in decreased expression of VCAN mRNA] CTD PMID:17109745 beta-D-glucosamine decreases expression ISO Vcan (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of VCAN mRNA CTD PMID:17109745 bezafibrate decreases expression ISO VCAN (Homo sapiens) 6480464 Bezafibrate results in decreased expression of VCAN mRNA CTD PMID:11522680 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VCAN mRNA CTD PMID:23704952 bisphenol A decreases expression ISO VCAN (Homo sapiens) 6480464 bisphenol A results in decreased expression of VCAN protein CTD PMID:31675489 bisphenol A decreases expression ISO Vcan (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of VCAN mRNA CTD PMID:29323181 and PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VCAN mRNA CTD PMID:30951980 and PMID:35598803 bisphenol A multiple interactions ISO VCAN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of VCAN mRNA CTD PMID:28628672 bisphenol A increases methylation ISO Vcan (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of VCAN gene CTD PMID:28505145 bisphenol A increases expression ISO Vcan (Rattus norvegicus) 6480464 bisphenol A results in increased expression of VCAN mRNA CTD PMID:25181051 Bisphenol B increases expression ISO VCAN (Homo sapiens) 6480464 bisphenol B results in increased expression of VCAN protein CTD PMID:34186270 bisphenol F multiple interactions ISO VCAN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VCAN mRNA CTD PMID:28628672 bisphenol F increases expression ISO VCAN (Homo sapiens) 6480464 bisphenol F results in increased expression of VCAN protein CTD PMID:34186270 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of VCAN mRNA CTD PMID:30951980 Brodifacoum increases expression ISO Vcan (Rattus norvegicus) 6480464 bromfenacoum results in increased expression of VCAN protein CTD PMID:28903499 butan-1-ol multiple interactions ISO VCAN (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of VCAN mRNA CTD PMID:29432896 butanal decreases expression ISO VCAN (Homo sapiens) 6480464 butyraldehyde results in decreased expression of VCAN mRNA CTD PMID:26079696 cadmium atom decreases expression ISO VCAN (Homo sapiens) 6480464 Cadmium results in decreased expression of VCAN mRNA CTD PMID:23369406 caffeine decreases expression ISO Vcan (Rattus norvegicus) 6480464 Caffeine results in decreased expression of VCAN mRNA CTD PMID:25868845 calcitriol decreases expression ISO VCAN (Homo sapiens) 6480464 Calcitriol results in decreased expression of VCAN mRNA CTD PMID:26485663 carbamazepine affects expression ISO VCAN (Homo sapiens) 6480464 Carbamazepine affects the expression of VCAN mRNA CTD PMID:25979313 carbofuran increases expression ISO Vcan (Rattus norvegicus) 6480464 Carbofuran results in increased expression of VCAN mRNA CTD PMID:20211217 carbofuran decreases expression ISO Vcan (Rattus norvegicus) 6480464 Carbofuran results in decreased expression of VCAN mRNA CTD PMID:30471306 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO VCAN (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to VCAN gene] CTD PMID:28238834 chloropicrin increases expression ISO VCAN (Homo sapiens) 6480464 chloropicrin results in increased expression of VCAN mRNA CTD PMID:26352163 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of VCAN mRNA CTD PMID:37019170 cisplatin affects expression ISO VCAN (Homo sapiens) 6480464 Cisplatin affects the expression of VCAN mRNA CTD PMID:23300844 cisplatin increases expression ISO VCAN (Homo sapiens) 6480464 Cisplatin results in increased expression of VCAN mRNA CTD PMID:27392435 cobalt dichloride decreases secretion ISO VCAN (Homo sapiens) 6480464 cobaltous chloride results in decreased secretion of VCAN protein CTD PMID:22079246 cobalt dichloride decreases expression ISO Vcan (Rattus norvegicus) 6480464 cobaltous chloride results in decreased expression of VCAN mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO VCAN (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of VCAN mRNA CTD PMID:19376846 copper atom multiple interactions ISO VCAN (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of VCAN mRNA CTD PMID:24690739 copper(0) multiple interactions ISO VCAN (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of VCAN mRNA CTD PMID:24690739 corticosterone decreases expression ISO Vcan (Rattus norvegicus) 6480464 Corticosterone results in decreased expression of VCAN mRNA CTD PMID:15755911 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VCAN mRNA] CTD PMID:18200517 cyclosporin A increases expression ISO Vcan (Rattus norvegicus) 6480464 Cyclosporine results in increased expression of VCAN mRNA CTD PMID:21865292 cyclosporin A decreases expression ISO VCAN (Homo sapiens) 6480464 Cyclosporine results in decreased expression of VCAN mRNA CTD PMID:34681664 cyclosporin A increases expression ISO VCAN (Homo sapiens) 6480464 Cyclosporine results in increased expression of VCAN mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO Vcan (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of VCAN mRNA CTD PMID:23640034 decabromodiphenyl ether decreases expression ISO VCAN (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of VCAN protein CTD PMID:31675489 deoxynivalenol decreases expression ISO VCAN (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of VCAN mRNA CTD PMID:31863870 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of VCAN mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO VCAN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of VCAN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VCAN mRNA CTD PMID:28628672 dexamethasone decreases expression ISO VCAN (Homo sapiens) 6480464 Dexamethasone results in decreased expression of VCAN mRNA CTD PMID:25047013 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of VCAN mRNA CTD PMID:22733784 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VCAN mRNA CTD PMID:29950665 diallyl trisulfide decreases expression ISO VCAN (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of VCAN mRNA CTD PMID:34995734 dibutyl phthalate decreases expression ISO Vcan (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of VCAN mRNA CTD PMID:21266533 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of VCAN mRNA CTD PMID:26934552 dimethylarsinous acid decreases expression ISO VCAN (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of VCAN mRNA CTD PMID:23876855 dioxygen multiple interactions EXP 6480464 [baysilon results in increased abundance of Oxygen] which results in increased expression of VCAN mRNA and [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VCAN mRNA CTD PMID:29156398 and PMID:30529165 dioxygen multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of VCAN mRNA CTD PMID:33729688 dioxygen increases expression ISO VCAN (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of VCAN mRNA CTD PMID:26516004 diquat decreases expression EXP 6480464 Diquat results in decreased expression of VCAN mRNA CTD PMID:36851058 disulfiram multiple interactions ISO VCAN (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of VCAN mRNA CTD PMID:24690739 diuron decreases expression ISO Vcan (Rattus norvegicus) 6480464 Diuron results in decreased expression of VCAN mRNA CTD PMID:25152437 dopamine increases expression ISO Vcan (Rattus norvegicus) 6480464 Dopamine results in increased expression of VCAN mRNA CTD PMID:21983523 dorsomorphin multiple interactions ISO VCAN (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of VCAN mRNA CTD PMID:19073829 doxorubicin decreases expression ISO VCAN (Homo sapiens) 6480464 Doxorubicin results in decreased expression of VCAN mRNA CTD PMID:29803840 doxorubicin increases expression ISO Vcan (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of VCAN mRNA CTD PMID:20211217 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of VCAN protein CTD PMID:19073829 ethanol decreases expression ISO VCAN (Homo sapiens) 6480464 Ethanol results in decreased expression of VCAN mRNA CTD PMID:28986285 ethanol increases expression EXP 6480464 Ethanol results in increased expression of VCAN mRNA CTD PMID:30319688 etoposide affects response to substance ISO VCAN (Homo sapiens) 6480464 VCAN protein affects the susceptibility to Etoposide CTD PMID:16217747 fenoldopam increases expression ISO Vcan (Rattus norvegicus) 6480464 Fenoldopam results in increased expression of VCAN mRNA CTD PMID:21983523 fenvalerate increases expression ISO Vcan (Rattus norvegicus) 6480464 fenvalerate results in increased expression of VCAN mRNA CTD PMID:30307764 furan increases expression ISO Vcan (Rattus norvegicus) 6480464 furan results in increased expression of VCAN mRNA CTD PMID:27387713 gentamycin decreases expression ISO Vcan (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of VCAN mRNA CTD PMID:33387578 hexadecanoic acid multiple interactions ISO VCAN (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VCAN mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of VCAN mRNA CTD PMID:30547786 indometacin multiple interactions ISO VCAN (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of VCAN mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VCAN mRNA CTD PMID:28628672 isoprenaline increases expression ISO Vcan (Rattus norvegicus) 6480464 Isoproterenol results in increased expression of VCAN mRNA CTD PMID:20211217 isotretinoin increases expression ISO VCAN (Homo sapiens) 6480464 Isotretinoin results in increased expression of VCAN mRNA CTD PMID:20436886 ivermectin decreases expression ISO VCAN (Homo sapiens) 6480464 Ivermectin results in decreased expression of VCAN protein CTD PMID:32959892 ketamine decreases expression ISO Vcan (Rattus norvegicus) 6480464 Ketamine results in decreased expression of VCAN mRNA CTD PMID:20080153 lead(0) affects splicing ISO VCAN (Homo sapiens) 6480464 Lead affects the splicing of VCAN mRNA CTD PMID:28903495 lidocaine increases expression ISO Vcan (Rattus norvegicus) 6480464 Lidocaine results in increased expression of VCAN mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO VCAN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 loliolide increases expression ISO VCAN (Homo sapiens) 6480464 loliolide results in increased expression of VCAN mRNA CTD PMID:31601058 mitoxantrone affects response to substance ISO VCAN (Homo sapiens) 6480464 VCAN protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 monosodium L-glutamate multiple interactions EXP 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of VCAN mRNA CTD PMID:22078008 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of VCAN mRNA CTD PMID:22078008 N-methyl-4-phenylpyridinium decreases expression ISO VCAN (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of VCAN mRNA CTD PMID:24810058 nickel atom increases expression ISO VCAN (Homo sapiens) 6480464 Nickel results in increased expression of VCAN mRNA CTD PMID:24768652 and PMID:25583101 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of VCAN mRNA CTD PMID:16166746 nickel sulfate decreases expression ISO VCAN (Homo sapiens) 6480464 nickel sulfate results in decreased expression of VCAN mRNA CTD PMID:22714537 nicotine increases expression ISO VCAN (Homo sapiens) 6480464 Nicotine results in increased expression of VCAN mRNA CTD PMID:23825647 oleic acid multiple interactions ISO VCAN (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of VCAN mRNA and [Palmitic Acid co-treated with Oleic Acid] affects the expression of VCAN mRNA CTD PMID:30547786 oxaliplatin multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VCAN mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of VCAN mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of VCAN mRNA CTD PMID:27106289 and PMID:34911549 ozone increases expression EXP 6480464 Ozone results in increased expression of VCAN mRNA CTD PMID:33026818 paclitaxel increases expression ISO Vcan (Rattus norvegicus) 6480464 Paclitaxel results in increased expression of VCAN mRNA CTD PMID:18754875 paracetamol decreases expression ISO VCAN (Homo sapiens) 6480464 Acetaminophen results in decreased expression of VCAN mRNA CTD PMID:21420995 paracetamol increases expression ISO Vcan (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of VCAN mRNA CTD PMID:33387578 paracetamol increases expression ISO VCAN (Homo sapiens) 6480464 Acetaminophen results in increased expression of VCAN mRNA CTD PMID:29067470 paraquat increases expression ISO Vcan (Rattus norvegicus) 6480464 Paraquat results in increased expression of VCAN mRNA CTD PMID:32680482 paraquat increases expression ISO VCAN (Homo sapiens) 6480464 Paraquat results in increased expression of VCAN mRNA CTD PMID:34681664 phenylephrine increases expression ISO Vcan (Rattus norvegicus) 6480464 Phenylephrine results in increased expression of VCAN mRNA CTD PMID:18158353 phenytoin increases expression ISO VCAN (Homo sapiens) 6480464 Phenytoin results in increased expression of VCAN mRNA CTD PMID:14741686 pirinixic acid multiple interactions ISO VCAN (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VCAN mRNA CTD PMID:19710929 potassium chromate increases expression ISO VCAN (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of VCAN mRNA CTD PMID:22714537 progesterone increases expression ISO Vcan (Rattus norvegicus) 6480464 Progesterone results in increased expression of VCAN mRNA CTD PMID:20726854 progesterone increases expression ISO VCAN (Homo sapiens) 6480464 Progesterone results in increased expression of VCAN mRNA CTD PMID:18692832 progesterone multiple interactions ISO VCAN (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of VCAN mRNA CTD PMID:20660070 rofecoxib decreases expression ISO VCAN (Homo sapiens) 6480464 rofecoxib results in decreased expression of VCAN mRNA CTD PMID:17070997 rotenone decreases expression ISO Vcan (Rattus norvegicus) 6480464 Rotenone results in decreased expression of VCAN mRNA CTD PMID:28374803 rotenone decreases expression ISO VCAN (Homo sapiens) 6480464 Rotenone results in decreased expression of VCAN mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO VCAN (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO VCAN (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of VCAN mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO VCAN (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 serpentine asbestos multiple interactions EXP 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos and Serpentine results in increased expression of VCAN mRNA] CTD PMID:21514415 serpentine asbestos increases expression EXP 6480464 Asbestos and Serpentine results in increased expression of VCAN mRNA CTD PMID:21514415 silicon dioxide decreases expression ISO VCAN (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of VCAN mRNA and Silicon Dioxide results in decreased expression of VCAN mRNA CTD PMID:25351596 and PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of VCAN mRNA CTD PMID:23221170 and PMID:29341224 silicon dioxide increases expression ISO VCAN (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of VCAN mRNA CTD PMID:23806026 silicon dioxide affects secretion ISO VCAN (Homo sapiens) 6480464 Silicon Dioxide analog affects the secretion of VCAN protein CTD PMID:25895662 silver atom decreases expression ISO VCAN (Homo sapiens) 6480464 Silver results in decreased expression of VCAN mRNA CTD PMID:26551752 silver(0) decreases expression ISO VCAN (Homo sapiens) 6480464 Silver results in decreased expression of VCAN mRNA CTD PMID:26551752 sirolimus increases expression ISO Vcan (Rattus norvegicus) 6480464 Sirolimus results in increased expression of VCAN mRNA CTD PMID:21865292 sodium arsenite decreases expression ISO VCAN (Homo sapiens) 6480464 sodium arsenite results in decreased expression of VCAN mRNA CTD PMID:23876855 sodium arsenite increases expression ISO VCAN (Homo sapiens) 6480464 sodium arsenite results in increased expression of VCAN mRNA CTD PMID:29301061 sodium arsenite affects methylation ISO VCAN (Homo sapiens) 6480464 sodium arsenite affects the methylation of VCAN gene CTD PMID:28589171 Soman increases expression ISO Vcan (Rattus norvegicus) 6480464 Soman results in increased expression of VCAN mRNA CTD PMID:19281266 sunitinib increases expression ISO VCAN (Homo sapiens) 6480464 Sunitinib results in increased expression of VCAN mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO Vcan (Rattus norvegicus) 6480464 Tacrolimus results in increased expression of VCAN mRNA CTD PMID:21865292 tert-butyl hydroperoxide decreases expression ISO VCAN (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of VCAN mRNA CTD PMID:15336504 testosterone multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VCAN mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO Vcan (Rattus norvegicus) 6480464 Carbon Tetrachloride affects the expression of VCAN mRNA CTD PMID:12734012 thioacetamide increases expression ISO Vcan (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of VCAN mRNA CTD PMID:34492290 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VCAN mRNA CTD PMID:29950665 topotecan multiple interactions ISO Vcan (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VCAN mRNA CTD PMID:25729387 topotecan affects response to substance ISO VCAN (Homo sapiens) 6480464 VCAN protein affects the susceptibility to Topotecan CTD PMID:16217747 topotecan increases expression ISO Vcan (Rattus norvegicus) 6480464 Topotecan results in increased expression of VCAN mRNA CTD PMID:25729387 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of VCAN mRNA CTD PMID:29279043 trichostatin A increases expression ISO VCAN (Homo sapiens) 6480464 trichostatin A results in increased expression of VCAN mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO VCAN (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VCAN mRNA CTD PMID:27188386 triclosan decreases expression ISO VCAN (Homo sapiens) 6480464 Triclosan results in decreased expression of VCAN mRNA CTD PMID:30510588 triclosan increases expression ISO VCAN (Homo sapiens) 6480464 Triclosan results in increased expression of VCAN mRNA CTD PMID:34681664 Triptolide increases expression ISO Vcan (Rattus norvegicus) 6480464 triptolide results in increased expression of VCAN protein CTD PMID:32519852 tris(2-butoxyethyl) phosphate affects expression ISO VCAN (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of VCAN mRNA CTD PMID:29024780 troglitazone increases expression ISO VCAN (Homo sapiens) 6480464 troglitazone results in increased expression of VCAN mRNA CTD PMID:19140230 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of VCAN mRNA CTD PMID:28973697 tunicamycin decreases expression EXP 6480464 Tunicamycin results in decreased expression of VCAN mRNA CTD PMID:17127020 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of VCAN mRNA CTD PMID:17127020 valproic acid affects expression ISO VCAN (Homo sapiens) 6480464 Valproic Acid affects the expression of VCAN mRNA CTD PMID:25979313 valproic acid decreases expression ISO VCAN (Homo sapiens) 6480464 Valproic Acid results in decreased expression of VCAN mRNA CTD PMID:27188386 more ... valproic acid multiple interactions ISO VCAN (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VCAN mRNA CTD PMID:27188386 valproic acid increases expression ISO VCAN (Homo sapiens) 6480464 Valproic Acid results in increased expression of VCAN mRNA CTD PMID:23179753 and PMID:26272509 vorinostat decreases expression ISO Vcan (Rattus norvegicus) 6480464 vorinostat results in decreased expression of VCAN mRNA CTD PMID:20060208 vorinostat increases expression ISO VCAN (Homo sapiens) 6480464 vorinostat results in increased expression of VCAN mRNA CTD PMID:26272509
